2019
DOI: 10.1128/jcm.01468-18
|View full text |Cite
|
Sign up to set email alerts
|

Blood Smears Have Poor Sensitivity for Confirming Borrelia miyamotoi Disease

Abstract: Borrelia miyamotoi disease (BMD) is a newly recognized borreliosis that is cotransmitted by ticks wherever Lyme disease is zoonotic. Unlike Borrelia burgdorferi sensu lato, the agent of Lyme disease, B. miyamotoi is closely related to relapsing fever spirochetes, such as Borrelia hermsii. Some authors have suggested that the disease caused by B. miyamotoi should be considered a hard-tick-transmitted relapsing fever, and thus, the main mode of confirming a diagnosis for that infection, microscopy to analyze a b… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 16 publications
0
7
0
Order By: Relevance
“…PCR detection of B. miyamotoi is often aimed at amplification of 16S rRNA or glycerophosphodiester phosphodiesterase ( glpQ ) or flagellin B ( flaB ) gene fragments. Due to the relatively short spirochetemia ( 15 ), PCR detection of B. miyamotoi is applicable only in the acute phase of disease or during a febrile relapse ( 10 , 16 ).…”
Section: Introductionmentioning
confidence: 99%
“…PCR detection of B. miyamotoi is often aimed at amplification of 16S rRNA or glycerophosphodiester phosphodiesterase ( glpQ ) or flagellin B ( flaB ) gene fragments. Due to the relatively short spirochetemia ( 15 ), PCR detection of B. miyamotoi is applicable only in the acute phase of disease or during a febrile relapse ( 10 , 16 ).…”
Section: Introductionmentioning
confidence: 99%
“…Spirochetes can be visualized in blood and CSF using dark-field microscopy, or with Giemsa staining or acridine orange staining [ 21 , 22 , 23 ]. Microscopy can confirm a Borrelia species infection; however, it cannot be used to distinguish between species and has low sensitivity [ 29 ]. In order to see spirochetes in a blood smear or CSF sample, the density needs to be greater than 10 4 cells/mL [ 11 , 26 ].…”
Section: Diagnosismentioning
confidence: 99%
“…Firstly, although most likely of little clinical utility, it is possible to isolate B. miyamotoi from blood of infected individuals (Wagemakers et al, 2014). Secondly, and of greater clinical relevance, DNA from B. miyamotoi sensu lato can be detected by molecular methods in blood (plasma or serum) (Platonov et al, 2011) or cerebrospinal fluid (CSF) (Hovius et al, 2013) and, albeit less sensitive, spirochetes can be directly visualized by dark-field microscopy (Telford et al, 2019). The above-mentioned diagnostic modalities can be used only in febrile episodes, during which spirochetemia occurs.…”
Section: Immunitymentioning
confidence: 99%